MedPath

Platelet Concentrate in Achilles Tendon Repair

Not Applicable
Completed
Conditions
Achilles Tendon Rupture
Soft Tissue Injury
Tendon Injury
Interventions
Biological: Autologous platelets
Biological: no injection
Registration Number
NCT00537784
Lead Sponsor
University Hospital, Linkoeping
Brief Summary

People operated for a rupture of the Achilles tendon receive a concentrate of their own platelets injected into the operated area. The study is randomized and single-blinded, with 20 treated patients and 20 controls, who get no injection. The primary endpoint is a mechanical property of the tendon after 12 weeks (modulus of elasticity), as measured by a special type of radiography. This radiography uses 0.8 mm metal markers, which are injected into the tendon. The tendon is mechanically loaded during radiography and its strain can be measured as increased distance between the markers. Other mechanical variables at 6, 12 and 52 weeks are secondary variables, as well as a validated patient-administrated questionaire at 1 year.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Achilles tendon rupture, age 18-65.
Exclusion Criteria
  • Any counterindication for surgical treatment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Autologous plateletsInjection of autologous platelet concentrate into repair site
2no injectionNo injection
Primary Outcome Measures
NameTimeMethod
Modulus of elasticity12 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Univ Hosp

🇸🇪

Linköping, Sweden

© Copyright 2025. All Rights Reserved by MedPath